News
Public · Published
PSNL Shareholder Notice: Personalis $16.25 per Share Merger Under Investigation on Behalf of Shareholders
BFA Law announced an investigation into Personalis's proposed take-private merger with Tempus AI, which is set to acquire all outstanding Personalis stock for $16.25 per share. The deal allows a mix of cash and stock, and the firm cites possible fiduciary-duty breaches and invites current shareholders to contact it.
Published:
Updated:
What happened
BFA Law announced an investigation into Personalis’s proposed take-private merger with Tempus AI, which is set to acquire all outstanding Personalis stock for $16.25 per share. The deal allows a mix of cash and stock, and the firm cites possible fiduciary-duty breaches and invites current shareholders to contact it.
Confirmed
Global impact / market context
If the deal closes, shareholders would give up direct ownership of Personalis in exchange for the announced mix of cash and stock. The investigation raises uncertainty about completion or terms; a delay or change could affect when investors receive proceeds and their value.
Analyst inference
This is an announced merger and an investigation, not a completed transaction or a finding of wrongdoing. Tempus owned 12.5% of Personalis’s common stock as of March 2026 and had a commercial relationship with Personalis since November 2023, connecting the companies beyond the proposed deal.
Confirmed
What to watch
- BFA Law’s investigation centers on possible fiduciary-duty breaches, meaning alleged failures by company decision-makers to act in shareholders’ interests; the article gives no specific alleged conduct or outcome. Confirmed
- Watch for updates on whether the merger proceeds with the announced $16.25-per-share price and mix of cash and stock, or whether the companies disclose any changes to those terms. Proposed
- A delay or revised terms could change the timing or value of shareholders’ proceeds, while a completed take-private would end their direct ownership of Personalis. Analyst inference
Evidence
- Original source link unavailable